Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gonzalez

Showing results (271-280 of 457) with videos related to

Pageof 46
Sort By:
The Journal of Antimicrobial Chemotherapy|March 16, 2013
Pharmacokinetics of maraviroc administered at 150 mg once daily in association with lopinavir/ritonavir in HIV-positive treatment-naive patientsAndrea Calcagno, Silvia Nozza, Daniel Gonzalez de Requena, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 12, 2023
A systematic review and evaluation of post-stroke depression clinical practice guidelinesJames Graham Cross, Brandon R May, Peter Q M Mai, et al.
Lupus Science & Medicine|January 8, 2022
Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomesStephen J Balevic, Daniel Weiner, Megan E B Clowse, et al.
Antiviral Therapy|June 21, 2011
Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patientsStefano Bonora, Daniel Gonzalez de Requena, Antonio D'Avolio, et al.
Clinical Therapeutics|July 2, 2016
Exposure Matching of Pediatric Anti-infective Drugs: Review of Drugs Submitted to the Food and Drug Administration for Pediatric ApprovalKanecia Zimmerman, Martin Putera, Christoph P Hornik, et al.
Arthritis Research & Therapy|June 8, 2017
Effect of tryptase inhibition on joint inflammation: a pharmacological and lentivirus-mediated gene transfer studyAlexandre Denadai-Souza, Camilla Moreira Ribeiro, Corinne Rolland, et al.
Journal of the Pediatric Infectious Diseases Society|September 25, 2025
Oral Cephalexin Population Pharmacokinetics and Target Attainment Analysis in Infants 7-60 Days OldAndrew S Haynes, Zixuan Wei, Marc H Scheetz, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2018
External Evaluation of a Gentamicin Infant Population Pharmacokinetic Model Using Data from a National Electronic Health Record DatabaseShufan Ge, Ryan J Beechinor, Christoph P Hornik, et al.
Clinical Pharmacokinetics|February 28, 2019
The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children's Oncology GroupRyan J Beechinor, Patrick A Thompson, Michael F Hwang, et al.
The American Journal of Tropical Medicine and Hygiene|December 19, 2006
Dengue hemorrhagic Fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002Mayling Alvarez, Rosmari Rodriguez-Roche, Lídice Bernardo, et al.
Pageof 46

Showing results (271-280 of 457) with videos related to

Sort By:
Pageof 46
The Journal of Antimicrobial Chemotherapy|March 16, 2013
Pharmacokinetics of maraviroc administered at 150 mg once daily in association with lopinavir/ritonavir in HIV-positive treatment-naive patientsAndrea Calcagno, Silvia Nozza, Daniel Gonzalez de Requena, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 12, 2023
A systematic review and evaluation of post-stroke depression clinical practice guidelinesJames Graham Cross, Brandon R May, Peter Q M Mai, et al.
Lupus Science & Medicine|January 8, 2022
Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomesStephen J Balevic, Daniel Weiner, Megan E B Clowse, et al.
Antiviral Therapy|June 21, 2011
Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patientsStefano Bonora, Daniel Gonzalez de Requena, Antonio D'Avolio, et al.
Clinical Therapeutics|July 2, 2016
Exposure Matching of Pediatric Anti-infective Drugs: Review of Drugs Submitted to the Food and Drug Administration for Pediatric ApprovalKanecia Zimmerman, Martin Putera, Christoph P Hornik, et al.
Arthritis Research & Therapy|June 8, 2017
Effect of tryptase inhibition on joint inflammation: a pharmacological and lentivirus-mediated gene transfer studyAlexandre Denadai-Souza, Camilla Moreira Ribeiro, Corinne Rolland, et al.
Journal of the Pediatric Infectious Diseases Society|September 25, 2025
Oral Cephalexin Population Pharmacokinetics and Target Attainment Analysis in Infants 7-60 Days OldAndrew S Haynes, Zixuan Wei, Marc H Scheetz, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2018
External Evaluation of a Gentamicin Infant Population Pharmacokinetic Model Using Data from a National Electronic Health Record DatabaseShufan Ge, Ryan J Beechinor, Christoph P Hornik, et al.
Clinical Pharmacokinetics|February 28, 2019
The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children's Oncology GroupRyan J Beechinor, Patrick A Thompson, Michael F Hwang, et al.
The American Journal of Tropical Medicine and Hygiene|December 19, 2006
Dengue hemorrhagic Fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002Mayling Alvarez, Rosmari Rodriguez-Roche, Lídice Bernardo, et al.
Pageof 46